Aquarius Surgical Technologies (Aquarius Surgical Technologies) Cyclically Adjusted PS Ratio : 0.42 (As of May. 26, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Aquarius Surgical Technologies Cyclically Adjusted PS Ratio?

As of today (2024-05-26), Aquarius Surgical Technologies's current share price is $0.0042. Aquarius Surgical Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $0.01. Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio for today is 0.42.

The historical rank and industry rank for Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio or its related term are showing as below:

AQQRF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.17 Med: 5 Max: 17.4
Current: 0.71

During the past years, Aquarius Surgical Technologies's highest Cyclically Adjusted PS Ratio was 17.40. The lowest was 0.17. And the median was 5.00.

AQQRF's Cyclically Adjusted PS Ratio is ranked better than
63.64% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.26 vs AQQRF: 0.71

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Aquarius Surgical Technologies's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.002. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.01 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation

Aquarius Surgical Technologies Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aquarius Surgical Technologies Cyclically Adjusted PS Ratio Chart

Aquarius Surgical Technologies Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cyclically Adjusted PS Ratio

Get a 7-Day Free Trial

4.56

7.74

5.29

2.02

0.33

Aquarius Surgical Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															0.63	0.33	0.34	0.35	0.36

Competitive Comparison of Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio falls into.

Aquarius Surgical Technologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio	=	Share Price	/	Cyclically Adjusted Revenue per Share
	=	0.0042	/	0.01
	=	0.42

Aquarius Surgical Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Aquarius Surgical Technologies's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare	=	Revenue per Share	/	CPI of Dec. 2023 (Change)	*	Current CPI (Dec. 2023)
	=	0.002	/	125.0724	*	125.0724
	=	0.002

Current CPI (Dec. 2023) = 125.0724.

Aquarius Surgical Technologies Quarterly Data

	Revenue per Share	CPI	Adj_RevenuePerShare
201403	0.000	98.604	0.000
201406	0.000	99.473	0.000
201409	0.000	99.394	0.000
201412	0.000	98.367	0.000
201503	0.000	99.789	0.000
201506	0.000	100.500	0.000
201509	0.000	100.421	0.000
201512	0.000	99.947	0.000
201603	0.000	101.054	0.000
201606	0.000	102.002	0.000
201609	0.000	101.765	0.000
201612	0.000	101.449	0.000
201703	0.000	102.634	0.000
201706	0.007	103.029	0.008
201709	0.009	103.345	0.011
201712	0.009	103.345	0.011
201803	0.018	105.004	0.021
201806	0.001	105.557	0.001
201809	0.005	105.636	0.006
201812	0.007	105.399	0.008
201903	0.002	106.979	0.002
201906	0.012	107.690	0.014
201909	0.008	107.611	0.009
201912	0.007	107.769	0.008
202003	0.006	107.927	0.007
202006	0.003	108.401	0.003
202009	0.003	108.164	0.003
202012	0.003	108.559	0.003
202103	0.011	110.298	0.012
202106	0.002	111.720	0.002
202109	0.005	112.905	0.006
202112	0.002	113.774	0.002
202203	0.003	117.646	0.003
202206	0.003	120.806	0.003
202209	0.001	120.648	0.001
202212	0.001	120.964	0.001
202303	0.001	122.702	0.001
202306	0.001	124.203	0.001
202309	0.002	125.230	0.002
202312	0.002	125.072	0.002

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Aquarius Surgical Technologies (OTCPK:AQQRF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Aquarius Surgical Technologies Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Aquarius Surgical Technologies's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Aquarius Surgical Technologies (Aquarius Surgical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aquarius Surgical Technologies Inc (OTCPK:AQQRF) » Definitions » Cyclically Adjusted PS Ratio

Comparable Companies

Traded in Other Exchanges

ASTI:Canada

Address

89 Scollard Street, Toronto, ON, CAN, M5R 1G4

Website

https://aquariussurgical.com

Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments, principally in the field of urology. The company derives revenue from the sale of medical devices and fiber-optic delivery devices. Geographically, it has a presence in Canada, the United States, and the Dominican Republic.